Nationwide Commercial Laboratory Seroprevalence Survey

Principal Investigator(s):  View help for Principal Investigator(s) United States Department of Health and Human Services. Centers for Disease Control and Prevention; Laboratory Surveillance

Version:  View help for Version V1

Name File Type Size Last Modified
Nationwide_Commercial_Laboratory_Seroprevalence_Survey.csv text/csv 895.8 KB 01/11/2026 12:01:PM
Nationwide_Commercial_Laboratory_Seroprevalence_Survey.pdf application/pdf 599.7 KB 01/10/2026 02:36:PM

Project Citation: 

United States Department of Health and Human Services. Centers for Disease Control and Prevention, and Laboratory Surveillance. Nationwide Commercial Laboratory Seroprevalence Survey. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2026-01-11. https://doi.org/10.3886/E243468V1

Project Description

Project Title:  View help for Project Title Nationwide Commercial Laboratory Seroprevalence Survey
Summary:  View help for Summary CDC is working with commercial laboratories to conduct large-scale geographic seroprevalence surveys to estimate the percentage of people who were previously infected with SARS-CoV-2, the virus that causes COVID-19 disease. The strategy involves working with state, local, territorial, academic, and commercial partners to better understand COVID-19 in the United States using serology (antibody) testing for surveillance (“seroprevalence surveys” or “serosurveys”). For the surveys, de-identified clinical blood samples are tested for antibodies to SARS-CoV-2. This dataset contains the data used to by the Nationwide Commercial Laboratory Seroprevalence Survey interactive visualization available at https://covid.cdc.gov/covid-data-tracker/#national-lab. Additional information is available at https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/commercial-lab-surveys.html. Read less
Original Distribution URL:  View help for Original Distribution URL https://data.cdc.gov/Laboratory-Surveillance/Nationwide-Commercial-Laboratory-Seroprevalence-Su/d2tw-32xv/about_data

Scope of Project

Subject Terms:  View help for Subject Terms covid; covid19; serosurveys; seroprevalence; prevalence; laboratory; coronavirus; covid-19; ncird-corvd
Collection Notes:  View help for Collection Notes (Downloaded 1/10/2026)


Related Publications

Download this project

Published Versions

V1 [2026-01-11]

Export Metadata

Dublin Core

DDI 2.5

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as received from the data depositor. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.